Trial Profile
Miltefosine for Brazilian Visceral Leishmaniasis
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 21 Apr 2020
Price :
$35
*
At a glance
- Drugs Miltefosine (Primary)
- Indications Visceral leishmaniasis
- Focus Therapeutic Use
- 14 Jul 2016 New trial record